Theralase Technologies Inc. V.TLT

Lets not fool ourselves................

[ggrellette]

A certain % of the float here are waiting on news to sell. Then there are others here who believe in the company and want them to succeed because it is in their best interest and not from a stock point of view but rather than a health issue. To have a break through in cancer would caterpult the stock to the heavens. HEADLINE NEWS WORLD WIDE WOULD READ "CANADIAN COMPANY FINDS CANCER CURE FOR.........................................". Sadly before that would happen the majors would be all over this company to buy it outright and/or Joint Venture with the company. Either scenario drives the stock 100 to 200% from these levels. 

So where is the news that would lead us to believe...........

[chry200030]

200%. Is that all? 

[rodrabal]

  THERALASE TECHNOLOGIES INC (CA: TLT)            Real-time   Last: 0.450   Change: 0.000   Volume: 109,056   Last Trade:  14:13  

[CancerSlayer]

2000%.  Is that all?

[robertshaw]

I am waiting 20000%, so I can use the profit to buyout ConocoPhillips surmont project 1&2, and Sunshine oilsand...

[ScienceFirst]

Only a big Pharma already in the urology indication would approach us as you don't enter such new market overnight.  And TLT would also refuse to jv with one that doesn't already have a footage in such market as it would mean no robust sales, so very low royalties. Any long investor here should already have a way to identify which ones are in this field.  There's an easy way

[gebremeskel]

I hate to break it to you ggrellette, but you're never going to see a headline that reads: "CANADIAN COMPANY FINDS CANCER CURE" You're going to have to make do with a series of sequential headlines: "CANADIAN COMPANY FINDS SAFE, CONVENIENT AND HIGHLY EFFICACIOUS TREATMENT FOR " cancer types - bladder cancer - glioblastoma - non small cell lung cancer - melanoma

[ScienceFirst]

Exact Gebremeskel.

[jmm1228]

Your message ggot everything correct except for the percentages.

[ScienceFirst]

Oncology treatments that show real chances of showing efficacy usually trade between 1.5G$US-4.5G$US, more or less, depending on different factors (market size, adjuvant or not, etc ...). Takeovers are a bit higher (3-10B$US).  Upfront payments for Ph. 2 data are above 1G$. The case of TLT, because of it low number of doses, stand alone treatment, high efficacy, minimal side effects